Whitehawk Therapeutics, Inc. Common Stock (WHWK)

• Market cap: $85.8M
• 1 day: 7.06%
• 5 days: 9.64%
• 1 month: 0.55%
• 3 months: 1.11%
• 6 months: -31.06%
• Year to date: -42.04%
• 1 year: 4.00%
• 5 years: -91.80%
• 10 years: -96.89%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 19

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0% more funds holding in top 10

Funds holding in top 10: 3 [Q1] → 3 (+0) [Q2]

3% less capital invested

Capital invested by funds: $56.4M [Q1] → $54.6M (-$1.75M) [Q2]

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

22% less funds holding

Funds holding: 50 [Q1] → 39 (-11) [Q2]

66.31% less ownership

Funds ownership: 128.79% [Q1] → 62.48% (-66.31%) [Q2]

83% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 12